Molecular Epidemiology of Lymphoma Patients
NCT00488553 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2012-02-24
Summary
Primary Objectives:
1. To enroll and obtain, through questionnaires, risk factor information on all study participants to develop detailed demographic, epidemiologic and behavioral profiles.
2. To assess the influence of relevant epidemiologic covariates such as age, gender, smoking and family history of cancer on the panel of susceptibility biomarkers.
3. To evaluate the role of genomic instability in development of lymphomas.
Conditions
Interventions
- BEHAVIORAL
-
Questionnaire
Questions about cancer risk factors, medical history, and family history of cancer.
Sponsors & Collaborators
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Randa El-Zein, MD, PhD · M.D. Anderson Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-08-31
- Primary Completion
- 2008-04-30
- Completion
- 2008-04-30
More Related Trials
-
Clinical and Genomic Factors for Prognosis of AIDS Primary Effusion Lymphoma
NCT02823327 ·Status: TERMINATED
-
Familial Investigations of Childhood Cancer Predisposition
NCT03050268 ·Status: RECRUITING
-
Molecular Analysis Of Solid Tumors
NCT01050296 ·Status: RECRUITING
-
Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma
NCT00026910 ·Status: COMPLETED
-
Effectiveness of Circulating DNA for Predicting the Relapse and Overall Survival in NHL Patients
NCT03079947 ·Status: UNKNOWN
-
Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
NCT00003863 ·Status: COMPLETED
-
Evaluation of Diagnostic Value of Molecular Markers in Renal Cancer
NCT00491621 ·Status: TERMINATED ·Phase: NA
-
Analysis of Biomarkers in Lymph Node Tissue
NCT04228796 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma
NCT00981097 ·Status: COMPLETED
-
Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms
NCT01390597 ·Status: COMPLETED
-
DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer
NCT00339859 ·Status: COMPLETED
-
Molecular and Genomic Profiling of Head and Neck Tumors
NCT00200486 ·Status: RECRUITING
-
Clinical Cohort of Lymphoma Patients in Malawi
NCT02835911 ·Status: RECRUITING
-
Role of Circulating Tumor DNA (ctDNA) From LIquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation
NCT03553550 ·Status: TERMINATED
-
Target Gene Sequencing for Advanced Stage, Relapsed or Refractory Natural Killer/T-cell Lymphoma
NCT04509804 ·Status: COMPLETED
-
The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical Study
NCT04957901 ·Status: RECRUITING
-
Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing
NCT06550427 ·Status: RECRUITING
-
Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
NCT01454297 ·Status: COMPLETED
-
Gene Abnormalities and Prognosis in Diffuse Large B-cell Lymphoma
NCT04825899 ·Status: UNKNOWN
-
The Aim is to Identify Recurrent Genomic Mutations and/or Predisposing Polymorphisms in Patients With Sporadic Cases of Multiple Myeloma
NCT05331313 ·Status: UNKNOWN
-
Genetic Testing in Young Adults With Cancer Study
NCT04533555 ·Status: COMPLETED ·Phase: NA
-
Association Between Mitochondrial DNA Content and Risk of Acute Leukemia
NCT03595969 ·Status: COMPLETED
-
Cell-free Circulating DNA in Primary Cutaneous Lymphomas
NCT02883517 ·Status: COMPLETED
-
Tumor Microenvironment Analysis of Prostate Cancer Metastasis
NCT05304858 ·Status: RECRUITING
-
Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions
NCT01457196 ·Status: COMPLETED ·Phase: NA